期刊文献+

Induced pluripotent stem cell technology for spinal cord injury: a promising alternative therapy 被引量:3

下载PDF
导出
摘要 Spinal cord injury has long been a prominent challenge in the trauma repair process. Spinal cord injury is a research hotspot by virtue of its difficulty to treat and its escalating morbidity. Furthermore, spinal cord injury has a long period of disease progression and leads to complications that exert a lot of mental and economic pressure on patients. There are currently a large number of therapeutic strategies for treating spinal cord injury, which range from pharmacological and surgical methods to cell therapy and rehabilitation training. All of these strategies have positive effects in the course of spinal cord injury treatment. This review mainly discusses the problems regarding stem cell therapy for spinal cord injury, including the characteristics and action modes of all relevant cell types. Induced pluripotent stem cells, which represent a special kind of stem cell population, have gained impetus in cell therapy development because of a range of advantages. Induced pluripotent stem cells can be developed into the precursor cells of each neural cell type at the site of spinal cord injury, and have great potential for application in spinal cord injury therapy.
出处 《Neural Regeneration Research》 SCIE CAS CSCD 2021年第8期1500-1509,共10页 中国神经再生研究(英文版)
基金 supported by the National Key Research and Development Program of China,No. 2017YFA0104304 (to BW),2017YFA0205400 (to PPS),and 2017YFA0506000 (to PPS) the National Natural Science Foundation of China,No. 81571213 (to BW) the Nanjing Medical Science and Technique Development Foundation of China,No. QRX17006 (to BW) the Nanjing Medical Science and Innovation Platform,No. ZDX16005 (to BW) the Innovation and Entrepreneurship Plan of Jiangsu Province (2019)(to BW)。
  • 相关文献

参考文献4

二级参考文献193

  • 1Sofroniew MV, Vinters HV. Astrocytes: biology and pathology.Acta Neuropathol 2010; 119: 7-35 [PMID: 20012068 DOI: 10.1007/s00401-009-0619-8].
  • 2Abbott NJ. Astrocyte-endothelial interactions and blood-brainbarrier permeability. J Anat 2002; 200: 629-638 [PMID: 12162730DOI: 10.1046/j.1469-7580.2002.00064.x].
  • 3Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ.Structure and function of the blood-brain barrier. Neurobiol Dis 2010;37: 13-25 [PMID: 19664713 DOI: 10.1016/j.nbd.2009.07.030].
  • 4Svendsen CN. The amazing astrocyte. Nature 2002; 417: 29-32[PMID: 11986650 DOI: 10.1038/417029a].
  • 5Chu T, Zhou H, Li F, Wang T, Lu L, Feng S. Astrocytetransplantation for spinal cord injury: current status and perspective.Brain Res Bull 2014; 107: 18-30 [PMID: 24878447 DOI: 10.1016/j.brainresbull.2014.05.003].
  • 6Nagelhus EA, Mathiisen TM, Ottersen OP. Aquaporin-4 in thecentral nervous system: cellular and subcellular distribution andcoexpression with KIR4.1. Neuroscience 2004; 129: 905-913[PMID: 15561407 DOI: 10.1016/j.neuroscience.2004.08.053].
  • 7Nielsen S, Nagelhus EA, Amiry-Moghaddam M, Bourque C,Agre P, Ottersen OP. Specialized membrane domains for watertransport in glial cells: high-resolution immunogold cytochemistryof aquaporin-4 in rat brain. J Neurosci 1997; 17: 171-180 [PMID:8987746].
  • 8Haj-Yasein NN, Vindedal GF, Eilert-Olsen M, Gundersen GA,Skare -, Laake P, Klungland A, Thorén AE, Burkhardt JM, OttersenOP, Nagelhus EA. Glial-conditional deletion of aquaporin-4 (Aqp4)reduces blood-brain water uptake and confers barrier function onperivascular astrocyte endfeet. Proc Natl Acad Sci USA 2011; 108:17815-17820 [PMID: 21990350 DOI: 10.1073/pnas.1110655108].
  • 9Nagelhus EA, Ottersen OP. Physiological roles of aquaporin-4 inbrain. Physiol Rev 2013; 93: 1543-1562 [PMID: 24137016 DOI:10.1152/physrev.00011.2013].
  • 10Amiry-Moghaddam M, Ottersen OP. The molecular basis of watertransport in the brain. Nat Rev Neurosci 2003; 4: 991-1001 [PMID:14682361 DOI: 10.1038/nrn1252].

共引文献16

同被引文献26

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部